The body has real tools for repairing pelvic tissue, and some of them are already in your bloodstream. That’s the idea behind regenerative gynecology, a growing area of women’s health that concentrates a patient’s own blood and uses it to treat vaginal dryness, urinary leakage, and other symptoms tied to hormonal and structural change. At Nervana Medical in Sandy, UT, we look at this field the way we look at any treatment: anatomy first, evidence before enthusiasm. Below is what the current research on Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) actually shows, and where it still falls short of the interest surrounding it.
It’s Tissue Repair, Not Symptom Masking
Most conventional treatments for vaginal dryness, lubricants and topical creams, work by covering a symptom. PRP works differently. When platelets are concentrated and activated, they release growth factors that trigger three specific biological processes: angiogenesis (new blood vessel formation), collagen synthesis, and nerve regeneration.
Rather than masking discomfort, PRP is thought to stimulate cell migration and proliferation, encouraging the body to replace aged or under-vascularized tissue with healthier tissue of its own making. It moves the goal from managing a symptom to repairing the structure underneath it. The research behind this is promising but still early.
A Non-Hormonal Option Worth Understanding
For postmenopausal women, Genitourinary Syndrome of Menopause (GSM) is often treated with estrogen therapy. Breast cancer survivors don’t always have that option; hormonal treatment is frequently paused or ruled out entirely, which leaves few tools for significant vaginal atrophy and dryness.
This is where PRP research has drawn particular interest. A Phase II pilot study led by Hersant B. et al. looked at postmenopausal breast cancer survivors using a combination of platelet concentrate and hyaluronic acid (HA), with the HA acting as both a moisturizing agent and a biomaterial scaffold. The study recorded improvements in Vaginal Health Index (VHI) scores and restored vaginal pH. For a group that has often had to choose between oncology safety and quality of life, that’s meaningful. It’s also one pilot study, not an established standard of care.
Early Research on Non-Surgical Approaches to Leakage
Stress Urinary Incontinence (SUI), involuntary leakage during physical activity, is a condition many women assume requires surgery or permanent accommodation. Pilot studies by Long CY et al. and Athanasiou S et al. have looked at periurethral PRP and PRF injections as a nonsurgical alternative. The Athanasiou data stands out: participants saw a 50.2% mean reduction in urine loss on the 1-hour pad test, and at six months, 80% reported their condition was at least improved.
That’s early-stage evidence, not a guarantee. It does suggest the same growth factors studied for tissue restoration elsewhere in the body may also support the structures involved in urinary control, which could offer a middle ground between conservative pelvic floor work and surgery.
PRF and the “Early Washout” Problem
Liquid PRP has one known limitation: the body can absorb it before its growth factors finish doing their work, often called early washout. Platelet-Rich Fibrin (PRF) was developed to address that. It forms a fibrin scaffold that acts as a biological reservoir, releasing growth factors gradually instead of all at once.
Separately, in vitro research such as the work by Aghajanova L et al. has shown PRP can stimulate proliferation in human endometrial cells. It’s an early “proof of principle” for intrauterine applications rather than a finished clinical protocol, but it’s part of why regenerative gynecology is being studied seriously and not just marketed to patients.
A High Safety Ceiling, With a Real Caveat
PRP and PRF are autologous, meaning they’re derived entirely from a patient’s own blood, so the risk of allergic reaction or rejection is essentially eliminated. That safety profile has allowed researchers to study its use for chronic conditions like vulvar lichen sclerosus, with early results showing reductions in pain and itching.
The caveat is worth taking seriously. This field isn’t standardized yet. Preparation techniques, platelet concentration, and equipment quality vary widely between providers, and outcomes vary right along with them. The biggest limitation isn’t what this technology might do; it’s the lack of larger, randomized controlled trials needed to move it from promising pilot data to an established protocol. Any provider offering PRP or PRF for pelvic health should be upfront about where the evidence currently stands.
Where This Fits at Nervana
Regenerative gynecology fits naturally with what draws many patients to an integrative med spa in Utah in the first place: an interest in treatments that work with the body’s own biology instead of around it. It belongs alongside the hormonal and wellness side of women’s health, including how estrogen and progesterone levels affect tissue quality, not in place of it. For patients navigating GSM, postmenopausal changes, or general questions about pelvic health, that bigger picture usually starts with a conversation rather than a single treatment decision. We have seen promising results among our patients at Nervana Medical!
Frequently Asked Questions
What’s the difference between PRP and PRF for pelvic health? PRP is a liquid concentrate of platelets and growth factors. PRF forms a fibrin scaffold that releases those same growth factors more gradually. Some providers use PRF specifically to avoid the early washout seen with liquid PRP.
Is PRP for pelvic health safe? Because it’s made from a patient’s own blood, the risk of allergic reaction or rejection is very low. Outcomes still depend heavily on preparation technique and provider experience, since the field isn’t standardized yet.
Can PRP help with vaginal dryness after menopause? Early pilot studies, including research in postmenopausal breast cancer survivors, have shown improvements in vaginal health index scores and pH when PRP is combined with hyaluronic acid. It’s considered a non-hormonal option worth discussing, particularly for women who can’t use estrogen therapy.
Is this treatment a replacement for pelvic floor therapy or surgery? No. Current research treats PRP and PRF as a possible middle-ground option for some patients, not a replacement for conservative care like pelvic floor exercises, or for surgery when it’s clinically indicated.
How established is this treatment, medically? It’s early-stage. Pilot study results are encouraging, but the field still needs larger, randomized trials before it can be called a standardized protocol. Anyone considering it should ask a provider specific questions about their technique and experience.
